Kathryn Tringale, MD, UC San Diego Health, San Diego, CA, discusses the safety of using radiation therapy prior to CAR T-cell therapy in relapsed/refractory (R/R) multiple myeloma. Dr Tringale highlights that radiation can be a safe and effective bridging strategy for patients to temporarily manage symptoms or cytoreduce the disease before CAR-T, and that its use does not appear to impact outcomes. This interview took place during the 18th International Conference on Malignant Lymphoma (18-ICML) in Lugano, Switzerland.
